Concepedia

Nizar El-Khalili

NE

4

Publications

291

Citations

4

H-Index

2010

Active since

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United States)

Wilmington University

Nizar El-Khalili is an author at AstraZeneca (Sweden) specializing in mental health, mood disorders, and social sciences.

Top concepts

Publications per year

2010–2014

4

Publications

4

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

Nizar El-Khalili, Mark Joyce, Sarah Atkinson et al. · The International Journal of Neuropsychopharmacology · 2010 · 178 citations · Full text

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆

Brian Bortnick, Nizar El-Khalili, Michael Banov et al. · Journal of Affective Disorders · 2010 · 79 citations

, , +12

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders

Nizar El-Khalili · Neuropsychiatric Disease and Treatment · 2012 · 17 citations · Full text

Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline

Borwin Bandelow, Michael Bauer, Eduard Vieta et al. · The World Journal of Biological Psychiatry · 2014 · 17 citations

Rows per page

1–4 of 4